This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571) Pulmonology, COPD (143) Health Services Research (482) Chronic Conditions (272) Immunology, Allergy, Rheumatology (90) Respiratory Medicine (83)

Published on in Vol 12 (2023)

This is a member publication of University of Oxford (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46741, first published .
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)

Authors of this article:

Imran Howell1, 2 Author Orcid Image ;   Mahdi Mahdi1, 2 Author Orcid Image ;   Mona Bafadhel3 Author Orcid Image ;   Timothy S C Hinks1, 2 Author Orcid Image ;   Sanjay Ramakrishnan1, 2 Author Orcid Image ;   James Melhorn1, 2 Author Orcid Image ;   Maisha Jabeen1, 2 Author Orcid Image ;   Ian D Pavord1, 2 Author Orcid Image
Article Authors Cited by (5) Tweetations (2) Metrics

Journals

  1. Celis-Preciado C, Leclerc S, Duval M, Cliche D, Larivée P, Lemaire-Paquette S, Lévesque S, Côté A, Lachapelle P, Couillard S. Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study. BMJ Open Respiratory Research 2023;10(1):e001932 View
  2. Howell I, Bratton D, Hynes G, Yancey S, Heaney L, Pavord I, Shrimanker R. Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo. ERJ Open Research 2024;10(4):00196-2024 View
  3. Howell I, Yang F, Brown V, Cane J, Marchi E, Azim A, Busby J, McDowell P, Diver S, Borg C, Heaney L, Pavord I, Brightling C, Chaudhuri R, Hinks T. Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma. Journal of Allergy and Clinical Immunology 2024;154(5):1146 View
  4. Couillard S, Jackson D, Pavord I, Wechsler M. Choosing the Right Biologic for the Right Patient With Severe Asthma. CHEST 2024 View
  5. Regard L, Lazureanu P, Pascal B, Laurichesse G, Rolland-Debord C. Efficacité et toxicité de la corticothérapie en cures courtes dans les pathologies bronchiques chroniques. Revue des Maladies Respiratoires 2024;41(9):696 View